Aadi Bioscience Stock Today
| AADI Stock | USD 1.75 0.07 4.17% |
Performance1 of 100
| Odds Of DistressOver 63
|
Aadi Bioscience is trading at 1.75 as of the 27th of April 2024. This is a 4.17 percent up since the beginning of the trading day. The stock's open price was 1.68. Aadi Bioscience has more than 63 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Aadi Bioscience are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of March 2024 and ending today, the 27th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of August 2017 | Category Healthcare | Classification Health Care |
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. The company has 24.55 M outstanding shares of which 1.1 M shares are presently shorted by private and institutional investors with about 4.46 trading days to cover. More on Aadi Bioscience
Moving together with Aadi Stock
| 0.82 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.76 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.67 | FHTX | Foghorn TherapeuticsInc Financial Report 13th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 8th of May 2024
Aadi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aadi Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aadi Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | David Lennon | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Aadi Bioscience report their recommendations after researching Aadi Bioscience's financial statements, talking to executives and customers, or listening in on Aadi Bioscience's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Aadi Bioscience. The Aadi consensus assessment is calculated by taking the average forecast from all of the analysts covering Aadi Bioscience. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Aadi Bioscience's historical financial statements, Aadi Bioscience is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Aadi Bioscience is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aadi Bioscience's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aadi Bioscience's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aadi Bioscience's financial leverage. It provides some insight into what part of Aadi Bioscience's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aadi Bioscience (AADI) is traded on NASDAQ Exchange in USA. It is located in 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272 and employs 89 people. Aadi Bioscience is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aadi Bioscience's market, we take the total number of its shares issued and multiply it by Aadi Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aadi Bioscience conducts business under Biotechnology sector and is part of Health Care industry. The entity has 24.55 M outstanding shares of which 1.1 M shares are presently shorted by private and institutional investors with about 4.46 trading days to cover.
Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Aadi Bioscience Probability Of Bankruptcy
Ownership AllocationAadi Bioscience holds a total of 24.55 Million outstanding shares. Over half of Aadi Bioscience's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Aadi Bioscience. Please watch out for any change in the institutional holdings of Aadi Bioscience as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aadi Ownership Details
Aadi Stock Price Odds Analysis
Coming from a normal probability distribution, the odds of Aadi Bioscience jumping above the current price in 90 days from now is about 88.7%. The Aadi Bioscience probability density function shows the probability of Aadi Bioscience stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Aadi Bioscience has a beta of -0.6393. This suggests as returns on the benchmark increase, returns on holding Aadi Bioscience are expected to decrease at a much lower rate. During a bear market, however, Aadi Bioscience is likely to outperform the market. Additionally, aadi Bioscience has an alpha of 0.1154, implying that it can generate a 0.12 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Aadi Bioscience to move above the current price in 90 days from now is about 88.7 (This Aadi Bioscience probability density function shows the probability of Aadi Stock to fall within a particular range of prices over 90 days) .
Aadi Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Aadi Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aadi Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aadi Bioscience's value.| Instituion | Recorded On | Shares | |
| Baker Bros Advisors Lp | 2023-12-31 | 251.7 K | |
| Citadel Advisors Llc | 2023-09-30 | 236.3 K | |
| 683 Capital Management Llc | 2023-12-31 | 200 K | |
| Northern Trust Corp | 2023-12-31 | 162.4 K | |
| Ameriprise Financial Inc | 2023-12-31 | 103.5 K | |
| Lion Point Capital, Lp | 2023-12-31 | 82.4 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 50 K | |
| Squarepoint Ops Llc | 2023-12-31 | 46.2 K | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 45.4 K | |
| Venbio Select Advisor Llc | 2023-12-31 | 2.8 M | |
| Longwood Capital Partners Llc | 2023-12-31 | 1.8 M |
Aadi Bioscience Historical Income Statement
Aadi Bioscience Income Statement is one of the three primary financial statements used for reporting Aadi's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Aadi Bioscience revenue and expense. Aadi Bioscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Aadi Bioscience's Gross Profit is increasing as compared to previous years. The Aadi Bioscience's current Cost Of Revenue is estimated to increase to about 2.9 M, while Operating Income is forecasted to increase to (68.3 M). View More FundamentalsAadi Stock Against Markets
Picking the right benchmark for Aadi Bioscience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aadi Bioscience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aadi Bioscience is critical whether you are bullish or bearish towards Aadi Bioscience at a given time. Please also check how Aadi Bioscience's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aadi Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Aadi Bioscience Corporate Management
Elected by the shareholders, the Aadi Bioscience's board of directors comprises two types of representatives: Aadi Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aadi. The board's role is to monitor Aadi Bioscience's management team and ensure that shareholders' interests are well served. Aadi Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aadi Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Desai | President, Founder | Profile | |
| Raymond Steitz | Senior Officer | Profile | |
| Bryan Ball | Chief Operations | Profile | |
| Marcy Graham | SVP Communications | Profile | |
| Stephen JD | Senior Counsel | Profile | |
| Brendan MBA | Chief Officer | Profile |
How to buy Aadi Stock?
Before investing in Aadi Bioscience, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Aadi Bioscience. To buy Aadi Bioscience stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Aadi Bioscience. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Aadi Bioscience stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Aadi Bioscience stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Aadi Bioscience stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Aadi Bioscience, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Aadi Stock please use our How to Invest in Aadi Bioscience guide.
Already Invested in Aadi Bioscience?
The danger of trading Aadi Bioscience is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aadi Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aadi Bioscience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aadi Bioscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.44) | Revenue Per Share 0.905 | Quarterly Revenue Growth 0.21 | Return On Assets (0.28) | Return On Equity (0.50) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.